4//SEC Filing
Symons Julian A. 4
Accession 0001610717-25-000045
CIK 0001799448other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:33 PM ET
Size
5.5 KB
Accession
0001610717-25-000045
Insider Transaction Report
Form 4
Symons Julian A.
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2025-02-28+21,693→ 21,693 totalExercise: $16.87Exp: 2035-02-28→ Common Stock (21,693 underlying)
Footnotes (1)
- [F1]1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from February 28, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
Documents
Issuer
Aligos Therapeutics, Inc.
CIK 0001799448
Entity typeother
Related Parties
1- filerCIK 0001824727
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:33 PM ET
- Size
- 5.5 KB